CELULARITY INC Share Price Today: Live Updates & Key Insights

CELULARITY INC share price today is $1.2, up -3.94%. The stock opened at $1.23 against the previous close of $1.27, with an intraday high of $1.25 and low of $1.2.

CELULARITY INC Share Price Chart

CELULARITY INC

us-stock
To Invest in {{usstockname}}
us-stock

CELULARITY INC Share Price Performance

$1.2 -0.0394(-3.94%) CELU at 23 Mar 2026 12:25 PM Biotechnology
Lowest Today 1.2
Highest Today 1.25
Today’s Open 1.23
Prev. Close 1.27
52 Week High 4.35
52 Week Low 1.01
Day’s Range: Low 1.2 High 1.25
52-Week Range: Low 1.01 High 4.35
1 day return -
1 Week return -4.72
1 month return -8.33
3 month return -7.63
6 month return -41.54
1 year return -33.51
3 year return -78.96
5 year return -98.79
10 year return -

CELULARITY INC Institutional Holdings

C V Starr & Co Inc 2.65

Vanguard Group Inc 2.35

Vanguard Total Stock Mkt Idx Inv 1.58

Geode Capital Management, LLC 0.56

Vanguard Institutional Extnd Mkt Idx Tr 0.48

BlackRock Inc 0.36

Fidelity Extended Market Index 0.30

Citadel Advisors Llc 0.27

State Street Corp 0.20

Valmark Advisers, Inc. 0.17

Jane Street Group LLC 0.14

HB Wealth Management, LLC 0.14

iShares Micro-Cap ETF 0.14

Bank of America Corp 0.13

Biltmore Family Office, LLC 0.12

Northern Trust Corp 0.12

NT Ext Equity Mkt Idx Fd - L 0.10

Keynote Financial Services, LLC 0.09

Fidelity Total Market Index 0.07

Northern Trust Extended Eq Market Idx 0.07

Fidelity Series Total Market Index 0.06

Royal Bank of Canada 0.06

Ipg Investment Advisors, LLC 0.06

Spartan Extended Market Index Pool F 0.05

Blackrock Extended Mkt Fund CF 0.05

NT Ext Equity Mkt Idx Fd - NL 0.05

Perennial Investment Advisors, LLC 0.05

Extended Equity Market Fund K 0.04

Susquehanna International Group, LLP 0.04

Spartan Total Market Index Pool G 0.04

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.04

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.04

IFP Advisors, LLC 0.04

SIMPLEX TRADING, LLC 0.03

Fidelity Nasdaq Composite Index 0.03

Vanguard Instl Ttl Stck Mkt Idx Tr 0.03

Tower Research Capital LLC 0.02

State St US Extended Mkt Indx NL Cl C 0.01

Vanguard U.S. Eq Idx £ Acc 0.01

BNYM Mellon SL Market Completion UC1 0.01

CELULARITY INC Market Status

Strong Buy: 0

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

CELULARITY INC Fundamentals

Market Cap 35.18 M

PB Ratio 9.8919

PE Ratio 0.0

Enterprise Value 101.25 M

Total Assets 132.68 M

Volume 109708

CELULARITY INC Company Financials

Annual Revenue FY24:22771000 22.8M, FY23:14788000 14.8M, FY22:17975000 18.0M, FY21:21335000 21.3M, FY20:14278000 14.3M

Annual Profit FY24:6755000 6.8M, FY23:3134000 3.1M, FY22:-1690000 -1.7M, FY21:11682000 11.7M, FY20:9346000 9.3M

Annual Net worth FY24:-196295000 -196.3M, FY23:-181408000 -181.4M, FY22:14192000 14.2M, FY21:-100118000 -100.1M, FY20:-208233000 -208.2M

Quarterly Revenue Q3/2025:5284000 5.3M, Q2/2025:5736000 5.7M, Q1/2025:18132000 18.1M, Q3/2024:9296000 9.3M, Q2/2024:12112000 12.1M

Quarterly Profit Q3/2025:3266000 3.3M, Q2/2025:494000 0.5M, Q1/2025:10789000 10.8M, Q3/2024:5413000 5.4M, Q2/2024:2503000 2.5M

Quarterly Net worth Q3/2025:-23073000 -23.1M, Q2/2025:-24524000 -24.5M, Q1/2025:-13293000 -13.3M, Q3/2024:-16098000 -16.1M, Q2/2024:9547000 9.5M

About CELULARITY INC & investment objective

Company Information Celularity Inc., a regenerative and cellular medicines company, focuses on addressing aging-related and degenerative diseases. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degenerative disease; and PDA-002 for treating facioscapulohumeral muscular dystrophy. The company is also developing pExo-001, a human postpartum placenta derived exosome product for the treatment of osteoarthritis. In addition, it produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey.

Organisation Biotechnology

Employees 123

Industry Biotechnology

CEO Dr. Robert Joseph Hariri M.D., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

CELULARITY INC FAQs

What is the share price of CELULARITY INC today?

The current share price of CELULARITY INC is $1.2.

Can I buy CELULARITY INC shares in India?

Yes, Indian investors can buy CELULARITY INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy CELULARITY INC shares in India?

You can easily invest in CELULARITY INC shares from India by:

Can I buy fractional shares of CELULARITY INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of CELULARITY INC?

CELULARITY INC has a market cap of $35.18 M.

In which sector does CELULARITY INC belong?

CELULARITY INC operates in the Biotechnology sector.

What documents are required to invest in CELULARITY INC stocks?

To invest, you typically need:

What is the PE and PB ratio of CELULARITY INC?

The PE ratio of CELULARITY INC is N/A and the PB ratio is 9.89.